Detection of Inflammatory Lesions by F-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Polymyositis and Dermatomyositis
Authors:
- Reika MaezawaRMReika Maezawa
- Kazuhiro KurasawaKKKazuhiro Kurasawa
- Harutsugu OkadaHOHarutsugu Okada
- Satoko AraiSASatoko Arai
- Takeshi FukudaTFTakeshi Fukuda
Open Access
- 1 July 2012
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 39 (8) , 1659-1665
Abstract
Objective.: To evaluate the usefulness of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging in the management of patients with inflammatory myopathy. We examined whether FDG-PET scanning detects myositis or extramuscular lesions in patients with polymyositis (PM) and dermatomyositis (DM).Methods.: FDG-PET imaging was performed in 24 patients with active inflammatory myopathy (PM, 11; DM, 13). The images were read by radiologists in a blinded manner. FDG uptake into muscles was judged positive when the intensity of muscles was higher than or equal to that of the liver. As controls, FDG imaging findings of patients with a lung mass and without muscle diseases were used. To investigate associations between FDG-PET findings and clinical/laboratory findings, the patients’ medical records were reviewed retrospectively.Results.: Increased FDG uptake in muscles was found in 8 of 24 (33%) patients. In 67 of 69 (97%) controls without muscle diseases, no muscle FDG uptake was detected. The sensitivity of FDG-PET to detect myositis was lower than that of electromyogram (EMG), magnetic resonance imaging, and muscle biopsy. There were no significant differences in clinical manifestations between patients with and without increased FDG uptake in muscles, although patients with FDG muscle uptake had a tendency to have extended myositis with endomysial cell infiltration. FDG-PET detected neoplasms in patients with associated malignancy. FDG uptake in lungs was found in 7 of 18 patients with interstitial lung disease.Conclusion.: FDG-PET imaging has limited usefulness for the evaluation of myositis in patients with PM/DM because of its low sensitivity, although it might be useful for detection of malignancy in these patients.Keywords
This publication has 24 references indexed in Scilit:
- Imaging of Inflammation by PET, Conventional Scintigraphy, and Other Imaging TechniquesJournal of Nuclear Medicine, 2010
- Immunotherapy of myositis: issues, concerns and future prospectsNature Reviews Rheumatology, 2010
- Functional Imaging of Inflammatory Diseases Using Nuclear Medicine TechniquesSeminars in Nuclear Medicine, 2009
- Molecular Imaging Techniques in Body ImagingRadiology, 2007
- Molecular Imaging: The Vision and Opportunity for Radiology in the FutureRadiology, 2007
- F-18 FDG PET/CT Detection of Mediastinal Malignancy in a Patient With DermatomyositisClinical Nuclear Medicine, 2007
- Polymyositis and dermatomyositisThe Lancet, 2003
- Accessory Findings on F-18 FDG Positron Emission Tomography in Bronchogenic CarcinomaClinical Nuclear Medicine, 2003
- Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort StudyAnnals of Internal Medicine, 2001
- Risk of Cancer in Patients with Dermatomyositis or PolymyositisNew England Journal of Medicine, 1992